OpenScholar

Search results

27 results found

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua

Publication: Website

Hallman, Mitchell, Adam Driscoll, Ryan Lubbe, and . 2020. “Lorem Ipsum Dolor Sit Amet, Consectetur Adipiscing Elit, Sed Do Eiusmod Tempor Incididunt Ut Labore et Dolore Magna Aliqua.”

News Headline 1

News: July 21, 2022

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus...

Lorem Ipsum

Person:

Lorem Ipsum, MD Co-creation targeted collaborate, triple bottom line radical segmentation.

Lorem Ipsum

Person:

Lorem Ipsum, MD Co-creation targeted collaborate, triple bottom line radical segmentation.

BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models.

Publication: Journal Article

Rauh, Ulrike, Guo Wei, Michael Serrano-Wu, Georgios Kosmidis, Stefan Kaulfuss, Franziska Siegel, Kai Thede, et al. 2024. “BRD-810 Is a Highly Selective MCL1 Inhibitor With Optimized in Vivo Clearance and Robust Efficacy in Solid and Hematological Tumor Models.”. Nat Cancer.

Jenny Serra-Vinardell

Person: Research Scientist II

Inaugural Merkin Prize in Biomedical Technology Celebrated at the Broad Institute of MIT and Harvard

Page